Big changes have come to Medicare’s prescription drug coverage, known as Part D, in 2026 that could affect how you pay for ...

In Washington, D.C., lawmakers are engaged in marathon talks about how to reduce health care costs. There haven’t been any ...

When Amazon, Berkshire Hathaway, and JPMorgan announced they were creating a new health care company in 2018, it raised the possibility of the purchasing power such a company could have. Although the ...

The U.S. Food and Drug Administration approved on Tuesday the first drug under its new fast-track program designed to shorten review time for a drug application.

President Donald Trump announced nine of the largest drugmakers in the U.S. and Europe agreed to voluntarily sell their ...

Participation in the 340B Drug Pricing Program by general acute care hospitals and critical access hospitals has not been associated with increased provision of uncompensated care. Objectives: To ...

Under the deals, each drugmaker will cut prices on most drugs sold to the Medicaid program for low-income people, senior ...

The 340B Drug Pricing Program was meant to help low-income patients, writes Rick Dowlearn, but it’s being used by hospitals ...

Facing mounting criticism, the nation’s most popular program to discourage alcohol and drug use by students announced here last week that it plans to change its strategy. Administrators of the program ...

Use of addiction medications in the jails doubled in 2025, while waitlists surged. A coalition of treatment experts calls for ...

The discovery and development of novel therapeutic agents for the treatment of malignancies is of vital importance to cancer patients. The discovery of effective anticancer agents reflects a ...